Clinical trials in urological oncology: COVID-19 and the potential need for a new perspective

    Thumbnail
    Citations
    Altmetric
    Author
    Teh, J; O'Connor, E; Coles-Black, J; Lawrentschuk, N
    Date
    2020-09-04
    Source Title
    World Journal of Urology
    Publisher
    SPRINGER
    University of Melbourne Author/s
    Lawrentschuk, Nathan; Coles-Black, Jasamine; O'Connor, Ellen; Teh, Jiasian
    Affiliation
    Surgery (Austin & Northern Health)
    Anatomy and Neuroscience
    Medical Education
    Metadata
    Show full item record
    Document Type
    Journal Article
    Citations
    Teh, J., O'Connor, E., Coles-Black, J. & Lawrentschuk, N. (2020). Clinical trials in urological oncology: COVID-19 and the potential need for a new perspective. WORLD JOURNAL OF UROLOGY, https://doi.org/10.1007/s00345-020-03416-4.
    Access Status
    Access this item via the Open Access location
    URI
    http://hdl.handle.net/11343/254397
    DOI
    10.1007/s00345-020-03416-4
    Open Access URL
    https://europepmc.org/articles/PMC7471589?pdf=render
    Abstract
    The COVID-19 pandemic has led to the suspension, termination or alteration of thousands of clinical trials as the health emergency escalated globally. Whilst the rapid suspension of certain clinical trials was necessary to ensure the safety of high-risk or vulnerable trial participants as well as healthcare workers, the long-term ramifications that this delay will have on the field of urologic oncology is unknown. The COVID-19 pandemic has highlighted the need to plan for and implement new strategies to advance our understanding of unmet areas of need in urologic oncology. The COVID-19 pandemic has led to the suspension, termination or alteration of thousands of clinical trials as the health emergency escalated globally. Whilst the rapid suspension of certain clinical trials was necessary to ensure the safety of high-risk or vulnerable trial participants as well as healthcare workers, the long-term ramifications that this delay will have on the field of urologic oncology is unknown. The COVID-19 pandemic has highlighted the need to plan for and implement new strategies to advance our understanding of unmet areas of need in urologic oncology.

    Export Reference in RIS Format     

    Collections